The cAMP response element-binding protein (CREB) is a nuclear transcription factor that is critical for normal and neoplastic hematopoiesis. Previous studies have demonstrated that CREB is a proto-oncogene whose overexpression promotes cellular proliferation in hematopoietic cells. Transgenic mice that overexpress CREB in myeloid cells develop a myeloproliferative disease with splenomegaly and aberrant myelopoiesis.
Introduction
Acute myeloid leukemia (AML) results from the accumulation of several genetic alterations that confer a proliferative or survival advantage to hematopoietic stem cells 1 .
Over 5000 total mutations with or without chromosomal aberrations in AML have been reported (http://cgap.nci.nih.gov/Chromosomes/) 2 . Recent studies suggest that specific chromosomal translocations are found in less than 40% of AML patients 3 . Furthermore, many of these genetic alterations are not sufficient to drive leukemogenesis. Therefore, identifying novel oncogenic alterations that cause leukemia and deciphering the signaling pathways that are affected is key to improving our understanding of this disease and identifying novel therapeutic targets.
The cAMP response element-binding protein (CREB) is a 43-kDa nuclear transcription factor that has been implicated in a number of cancers, including leukemias 4, 5 . The transcription factor CREB is downstream of cell surface receptors and mitogens that are critical for normal and neoplastic hematopoiesis [6] [7] [8] [9] . We previously reported that CREB is a proto-oncogene whose overexpression promotes cellular transformation of hematopoietic cells. Transgenic mice overexpressing CREB in the myeloid lineage cells develop a myeloproliferative/myelodysplastic syndrome (MPD/MDS) after one year 6, 9 .
Additionally, a majority of patients with AML and acute lymphoid leukemia (ALL) overexpress CREB in the bone marrow 6, 8 .
Previous reports demonstrated that 80% of patients with AML overexpressed CREB by Western blot analysis and ELISA 8 . CREB was also phosphorylated and actively bound to the cyclic AMP Response Element (CRE) consensus site at diagnosis but not in remission or in non-leukemia control samples.
For personal use only. on . by guest www.bloodjournal.org From Retroviral insertional mutagenesis (RIM) or retroviral tagging is a powerful tool that has been used for oncogene discovery [10] [11] [12] [13] [14] . In this study, RIM was employed to accelerate myeloid leukemia in CREB transgenic (TG) mice and to identify CREB cooperating oncogenes. We inoculated CREB TG mice with the MOL4070LTR retrovirus. MOL4070LTR is a Moloney MuLV-based retrovirus capable of inducing myeloid leukemia at a higher frequency 15 . In our mutagenesis screen, the sox4 transcription factor was identified as a potential cooperating oncogene. Retroviral transduction studies demonstrated that aberrant expression of sox4 synergizes with CREB to increase proliferation, self-renewal and survival of bone marrow cells in culture.
Furthermore, increased protein expression of Sox4, CREB, and phosphorylated CREB was observed in the majority of blast cells from AML patients. Taken together, our results suggest that sox4 and CREB cooperate to enhance myeloid cell proliferation.
Materials and Methods

Plasmid Constructs
Retroviral vectors pMIG (MSCV-IRES-GFP) and pMIG-Sox4 were kindly provided by A. Perkins. The pMIG-Sox4 vector was constructed by subcloning murine sox4 cDNA from pIRES-Sox4 into the multiple cloning site of pMIG 16 .
Cell Culture
Human AML cell line HL60, ML-2, NB4, THP1, MV4;11, K562 and NOMO (American Type Culture Collection) were cultured in media supplemented with 10% FBS.
Retroviral Infection
The MOL4070LTR retrovirus was propagated and harvested as previously described (23). Newborn neonatal pups were inoculated with 1x10 5 
infectious particles of
For personal use only. on . by guest www.bloodjournal.org From 6 MOL4070LTR retrovirus in 0.1 ml of medium intraperitoneally, 1-3 days after birth. C57BL/6 wild type (WT) or CREB transgenic (TG) mice were housed and cared for in accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals. The human mrp8 promoter upregulates CREB in macrophage and monocytic lineage cells in CREB TG mice 6, 9 . Mice were under daily observation for signs and symptoms of leukemia, which include, lethargy, labored breathing, lordokyphosis and abdominal distention. Mice were euthanized when these symptoms were observed. All murine studies were approved by the UCLA IACUC.
Pathologic Evaluation and Phenotype Analysis
Moribund mice were euthanized and liver, spleen and bone marrow were harvested for analysis. Paraffin-embedded tissue sections were stained with hematoxylin and eosin (H&E), and cytospin slides were prepared from bone marrow cell suspensions and stained with Wright-Giemsa. 
Ligation mediated PCR
Genomic DNA from affected mice was harvested from splenocytes, restricted, ligated to adapters, and amplified using adapter and viral specific primers. Retroviral integration sites were cloned using LM-PCR. Amplicons were purified (Qiagen, Valencia, CA), BSA, 2.5 ng/mL murine stem cell factor (SCF), 10 ng/mL murine interleukin-3 (IL-3), and 25 ng/mL human IL-6 and 100mM 2-mercaptoethanol. Cells were plated into a well coated with retronectin (Clonetech Laboratories, Madison, WI), incubated with viral supernatant in the presence of the same cytokines, and harvested after 24 to 48 hrs. Viral supernatant was subsequently removed and fresh media was added to cultures. The transductants were then allowed to recover and expand for 24 hours prior to sorting for the green fluorescent protein (GFP) selectable marker.
Hematopoietic progenitor assays
Methylcellulose-based culture (MC) of bone marrow cells (5-10,000 GFP positive cells/ml of Methocult) was performed using MethoCult GF M3434 (StemCell 
Western blot analysis
Protein lysates were separated using SDS-PAGE. Immunoblotting was performed with anti-CREB (UBI, New York, NY), anti-actin (Sigma-Aldrich, St. Louis, MO), and antisox4 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA), as previously described 9. .
Chromatin immunoprecipitation
Chromatin were also included as controls. Informed written consent was obtained from all subjects before bone marrow samples were taken, in compliance with the Helsinki protocol.
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Results
CREB transgenic mice infected with retrovirus develop AML with shorter latency
We previously showed that human mrp8-CREB TG mice, which overexpress CREB in macrophage and monocytic cells, develop MPD and MDS but not AML after one year 6, 9 . This suggests that the transcription factor CREB is a relatively weak protooncogene and insufficient to cause leukemia. To identify genes that cooperate with CREB, we sought to investigate whether these mice would have an increased incidence of AML following MOL4070LTR infection. Inoculation of CREB TG or wild type (WT) newborn mice with the MOL4070LTR retrovirus accelerated acute leukemias in both groups. However, the latency for disease development was significantly decreased in our CREB TG mice ( Figure 1A Figure 1) . In total, bone marrow cells from 34 TG mice were immunophenotyped and the majority of leukemias were of myeloid origin (74% or 25/34 total mice analyzed) ( Figure 2C ). Infected WT mice had a decreased penetrance for myeloid disease compared to TG (38% or 8/21 mice analyzed; p=0.01). These results indicate that the MOL4070LTR retrovirus accelerates myeloid leukemia in CREB TG mice with higher penetrance (p<0.05 between myeloid and lymphoid incidence in WT and TG infected mice) resulting in more rapid disease progression compared to infected WT mice.
Identification of integration sites
To identify possible cooperating oncogenes, genomic DNA was subjected to LM-PCR (long-mediated PCR) analysis to amplify genomic sequences upstream of the virus 21 . Genomic DNA from spleens was harvested from mice with leukemia and subjected to Southern blot analysis to verify retroviral integration (data not shown). These sequences were mapped to the mouse genome to identify the chromosomal location. Blast analysis of retroviral integration sites (RIS) was performed on the publicly available Ensembl database and compared to known common integration sites on the Retroviral Tagged Cancer Gene Database (RTCGD http://rtcgd.ncifcrf.gov/) 22 .
We identified over 100 retroviral integration sites (RISs) 100 kb from genes and several common integration sites (CISs integration sites in greater than two mice) in MOL4070LTR infected CREB TG mice that developed AML (Table I) . Sequencing of integration sites identified several previously known oncogenes, such as Evi1/Mds, Evi5/Gfi1, Myb/Ahi, and Ras. Common integration sites identified in multiple mice include, sox4, Evi5/Gfi1, Myb/Ahi, Cbfa2t3. The highest incidence of integration in the mutagenesis screen was found to be in the sox4 gene (Table I) . Thirty-two percent of the TG mice that were analyzed by LM-PCR contained sox4 retroviral integration (8/25
CREB TG mice with myeloid leukemia analyzed). Of four myeloid leukemia cases screened in WT mice, none possessed retroviral integration in or nearby the sox4 gene.
Integration of the sox4 gene was identified both upstream and downstream of the coding region, indicating that retroviral integration at this site possibly acts to insertionally activate sox4 expression. We confirmed overexpression of the sox4 gene by performing real time PCR analysis on bone marrow from CREB TG mice that developed AML and possessed sox4 retroviral integration ( Figure 3 ). These data suggest the possibility that sox4 deregulation cooperates with CREB to accelerate myeloid cell transformation.
Sox4 and CREB increase proliferation and self-renewal in vitro
The goal of our RIM screen was to identify genes that potentially cooperate with CREB to accelerate myeloid leukemia. Since the CREB transgene is expressed under the control of the hMRP8 promoter in the monocytic and macrophage lineage, we analyzed only myeloid leukemias that developed in our mice. To study potential cooperation between CREB and Sox4, we analyzed the in vitro effects of Sox4 overexpression in mouse bone marrow cells from CREB TG or WT mice. Retroviral constructs that 
Expression of CREB and its target genes
To investigate the underlying molecular mechanism by which the Sox4 and CREB work cooperatively to enhance the proliferation of myeloid cells, we extracted RNA from WT and TG bone marrow transductants and performed quantitative real-time PCR analysis to examine of CREB and its known target genes. Our results demonstrated that retroviral transduction of Sox4 into WT bone marrow cells resulted in increased CREB expression by 2.3-fold ( Figure 6A ). This difference in CREB expression between WT vector (WV) and WT sox4 (WS) was significant (by t-test, p<0.001). When both CREB and Sox4 were overexpressed in normal mouse bone marrow progenitors (TV vs.
TS), we observed an eleven-fold increase in CREB expression ( Figure 6A ). Sox4
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To determine whether Sox4 increases expression of CREB target genes, we performed quantitative real-time PCR analysis using primers against known CREB target genes, cyclin D1, bcl-2, and c-fos. We found that the expression of cyclin D1, a regulator of G1 to S transition, followed a similar pattern as CREB expression and coincided with our results demonstrating increased percentage of cells in S phase 6, 23 . Cyclin D1 expression is slightly increased in WT sox4 transductants (4.6-fold), further increased in the TG mock transduced bone marrow cells (15.5-fold), and was highest in CREB and Sox4 overexpressing cells (45.5-fold, Figure 6C ). We also observed a similar increase in the expression of bcl2 in Sox4 transduced CREB TG bone marrow cells compared to WT or vector control transduced bone marrow cells ( Figure 6D ). Similarly, we observed an increase in the expression of c-fos in sox4 transduced CREB TG bone marrow cells compared to vector transduced cells, although not as dramatic (Tukey post-ANOVA p<0.05; Figure 6E ). Increase in c-fos expression in WT bone marrow progenitors transduced with Sox4 was minimal and not significant. Therefore, increased proliferation in the presence of sox4 and CREB overexpression may be due to the effects of known CREB downstream target genes.
To examine the contribution of known Sox4 target genes, we performed real-time quantitative PCR for PU.1, β-catenin, tgf-β, p53, and notch. Gli-1 was also examined but
was not expressed in progenitor cells transduced with vector or Sox4 retrovirus (data not shown). The results demonstrated a lesser yet statistically significant increase in Sox4
For personal use only. on . by guest www.bloodjournal.org From target gene expression, but not as dramatic as the increase in CREB expression (Supplementary Figure 4) . Therefore, although known Sox4 target genes are elevated, a greater effect was observed on CREB expression and known CREB target genes suggesting that pathways downstream of CREB, more than other Sox4 target genes, play an important role in myeloid cell proliferation, cell cycle progression, and survival.
CREB is a direct target of Sox4
To test the possibility that Sox4 increases CREB expression and hematopoietic progenitor cells proliferation through a direct interaction, we investigated whether CREB could be a downstream target of Sox4. We identified 5 putative Sox4 binding sites 
Characterization of sox4 expression in hematopoiesis
Our functional studies demonstrated that overexpression of Sox4 has the ability to enhance the self-renewal and survival properties of mouse bone marrow cells in culture.
We hypothesized that Sox4 could perhaps play a role in progenitor or stem cell maintenance and function. Quantitative real time PCR analysis was performed on distinct bone marrow cell populations ( Figure 6F and 6G and Supplementary Figure 3) .
Gene expression analysis showed that Sox4 was expressed at low levels in the majority of Although these data do not establish the Sox4 as a stem cell gene, it does suggest that it is a gene expressed in immature progenitors and may play a role in early hematopoiesis.
Elevated CREB and Sox4 expression in AML patients
To examine Sox4 expression in primary AML patient bone marrow samples at 
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of evidence suggesting that CREB overexpression contributes to transformation, it is not sufficient to induce myeloid leukemia. Similar observations have been described with other mouse models of leukemia, including AML1-ETO, PML-RARα, and FLT3-internal tandem duplication (ITD) transgenic mice, which result in myeloproliferative disorders but not full transformation to AML [24] [25] [26] [27] . These findings are consistent with the fact that myeloid leukemias result from the accumulation of multiple genetic alterations.
In this study, we sought to use RIM to accelerate leukemogenesis in our CREB TG mice and identify known or novel oncogenes that enhance transformation with CREB. Our RIM screen successfully accelerated leukemogenesis in our CREB TG mice with decreased latency compared to WT mice. We identified greater than 100 RIS, some of which potentially cooperate with CREB in the development of human AML. Many of the integration sites identified in this study are well-characterized oncogenes in myeloid leukemia, including Gfi1, Myb Cbfa2t3h, and Ras, which encode members of signaling pathways that play a role in proliferation, survival, differentiation, and cell cycle regulation [28] [29] [30] [31] [32] [33] .
The leukemias generated by this study contained more than one retroviral integration site (3-8 RIS per tumor). Our mutagenesis screen also identified genes whose functions are not fully known in myeloid cells. We found recurrent integration of virus in close proximity to the sox4-coding region in our CREB TG mice that developed myeloid disease. The role of this gene in myelopoiesis and myeloid leukemia is not well understood. Sox4 deficient mice are embryonic lethal and die due to cardiac failure and impaired lymphocyte development [34] [35] [36] . In adult mice, the sox4 gene is expressed in the gonads, thymus, lymphocytes and heart and it is thought to regulate cell fate and
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Sox4 has also been shown to be overexpressed in breast cancer cell lines and is thought to potentiate transformation by regulating the expression of breast cancer oncogene ErbB2 43 . Given that Sox4 plays a key role in development and cell fate, one can hypothesize that re-expression of this gene in differentiated cells could result in the dedifferentiation of mature cells with increased self-renewal and anti-apoptotic properties.
In other RIM studies, Sox4 has been identified as a site of retroviral integration Protein expression of Sox4, CREB, and phosphoCREB was quantitated using Reverse Phase Protein Array using bone marrow samples from 66 patients with newly diagnosed childhood AML (age range 0-18 years). Expression is represented as fold change relative to normal bone marrow and displayed on a logarithmic scale. Pearson correlations (r) for
